NCT04014413View on ClinicalTrials.gov

Safety and Efficacy of Fecal Microbiota Transplantation

NARecruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

October 31, 2030

Study Completion Date

October 31, 2030

Conditions
Crohn DiseaseUlcerative ColitisCeliac DiseaseIrritable Bowel SyndromeFunctional DysphoniaConstipationClostridium Difficile InfectionDiabetes MellitusObesityMultidrug -Resistant InfectionHepatic EncephalopathyMultiple SclerosisPseudo-ObstructionCarbapenem-Resistant Enterobacteriaceae InfectionVancomycin Resistant Enterococci InfectionMultiple Organ Dysfunction SyndromeDysbiotic Bowel SyndromeMRSA EnteritisPseudomembranous EnterocolitisAlopeciaAutismGraft-versus-host DiseaseIdiopathic Thrombocytopenic PurpuraAtopy or AllergyLiver DiseaseAlcohol DependencePsoriatic Arthropathy
Interventions
PROCEDURE

Fecal Microbiota Transplantation

Fecal microbiota transplantation

Trial Locations (1)

000000

RECRUITING

The Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER